Camden National Corporation filed an 8-K on November 5, 2026, disclosing under Regulation FD that it had prepared an investor presentation for upcoming investor meetings, furnished as Exhibit 99.1.
CRA International, Inc. filed an 8-K on November 5, 2026, reporting financial results for its fiscal quarter ended October 3, 2026, and announcing a quarterly cash dividend of $0.67 per share on its common stock.
Processa Pharmaceuticals, Inc. filed Definitive Additional Materials (DEFA14A) on November 5, 2026, disclosing a stockholder letter explaining the July 2026 Vidya Therapeutics acquisition, the resulting capitalization structure, and the company's development plans for lead candidate VT-7208.
OFA Group filed a Form 8-K on November 5, 2026, disclosing a 10-for-1 share consolidation of all Class A ordinary shares, effective November 10, 2026, to support continued listing on the Nasdaq Capital Market.
White Mountains Insurance Group, Ltd. filed a Form 8-K on November 5, 2026, announcing its results for the three and nine months ended September 30, 2026, along with detailed disclosures of 14 non-GAAP financial measures used in the accompanying press release.
Acorn Energy, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter net income attributable to stockholders of $940,000 and disclosing a completed acquisition that added goodwill and intangibles to …
International Seaways, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting sharply higher revenues and net income compared with the same periods in 2025.
Avalo Therapeutics, Inc. filed a Form 8-K on November 5, 2026, disclosing the entry into a new at-the-market equity offering agreement with Jefferies LLC and the simultaneous termination of its prior sales agreement with TD Securities (USA) LLC.
AudioCodes Ltd. filed a Form 6-K with the SEC on November 5, 2026, disclosing the adoption and approval of a Rule 10b5-1 stock trading plan to repurchase the company's ordinary shares.
IBM, the Quantum Science Center at Oak Ridge National Laboratory, and AMD announced on November 5, 2026, the launch of a co-design platform for quantum error correction that co-locates IBM quantum computers with ORNL's Umbra High-Performance Computing system powered by AMD hardware.